Cite
HARVARD Citation
Lim, S. et al. (2020). Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. BMJ open diabetes research and care. 8 (1), p. . [Online].